BIOMAT Database Logo BIOMAT Database Logo

Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with cystic fibrosis. 1979

Y Weisman, and E Reiter, and R C Stern, and A Root

UI MeSH Term Description Entries
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol

Related Publications

Y Weisman, and E Reiter, and R C Stern, and A Root
Serum 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D concentrations in femoral neck fracture.
October 1978, British medical journal,
Y Weisman, and E Reiter, and R C Stern, and A Root
Effect of iron on serum 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D concentrations.
September 1992, The American journal of clinical nutrition,
Y Weisman, and E Reiter, and R C Stern, and A Root
Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with various types of renal disease.
December 1980, Clinical nephrology,
Y Weisman, and E Reiter, and R C Stern, and A Root
25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
February 1981, Annals of clinical research,
Y Weisman, and E Reiter, and R C Stern, and A Root
Bone marrow and serum concentrations of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1 alpha,25-dihydroxyvitamin D in patients with leukemia and normal subjects.
August 1989, Journal of nutritional science and vitaminology,
Y Weisman, and E Reiter, and R C Stern, and A Root
Reference values for 24,25-dihydroxyvitamin D and the 25-hydroxyvitamin D/24,25-dihydroxyvitamin D ratio.
September 2019, Clinical chemistry and laboratory medicine,
Y Weisman, and E Reiter, and R C Stern, and A Root
Seasonal variation in paired maternal-newborn serum 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D concentrations in Israel.
April 1987, Israel journal of medical sciences,
Y Weisman, and E Reiter, and R C Stern, and A Root
Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
March 1999, Kidney international,
Y Weisman, and E Reiter, and R C Stern, and A Root
Simultaneous determination of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in plasma or serum.
October 1981, Clinical chemistry,
Y Weisman, and E Reiter, and R C Stern, and A Root
Changes in 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D during pregnancy.
September 1979, American journal of obstetrics and gynecology,
Copied contents to your clipboard!